Derivation of cut‐offs for plasma neurofilament light in clinical routine using healthy subjects aged between 5‐90
Joel Simrén(University of Gothenburg), Kaj Blennow(Sahlgrenska University Hospital), Lars Nyberg(Umeå University), Henrik Zetterberg(University of Wisconsin–Madison), Marc Suárez‐Calvet(Pasqual Maragall Foundation), Barbara Borroni(Centro San Giovanni di Dio Fatebenefratelli), Johan Gobom(Sahlgrenska University Hospital), Herman Depypere, Ulf Andréasson(Sahlgrenska University Hospital)
Cited by 0
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k